@MarkFordem 11/02/2019 21:23Amgen, Inc. (NASDAQ:AMGN) issued its earnings results on Tuesday, January, 29th. The medical research company reported $3.42 EPS for the quarter, beating analysts' consensus estimates of $3.26 by $0.16. The medical research company earned $6.23 billion during the quarter, compared to the consensus estimate of $5.88 billion. Amgen had a net margin of 35.35% and a return on equity of 66.74%. During the same quarter in the previous year, the business posted $2.89 EPS.NASDAQ:AMGN - Stock Price, News, & Analysis for Amgen | MarketBeat#1 de 6
@MarkFordem 11/02/2019 21:24https://seekingalpha.com/article/4236519-amgens-amgn-ceo-bob-bradway-q4-2018-results-earnings-call-transcript#2 de 6